Author

Debi Johnson

Observed name: D. Johnson

Institution: American Society of Nephrology

Observed institutions: The University of Melbourne, Peter MacCallum Cancer Centre, American Society of Nephrology

OpenAlex ID: A5113060464

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

2018 · Olga Kondrashova, Monique Topp, et al. · Nature Communications · 296

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

2024 · Ksenija Nesic, John J. Krais, et al. · Molecular Cancer · 36

Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer

2023 · Nikki L. Burdett, Madelynne O. Willis, et al. · Scientific Reports · 6

Patient and Physician Perceptions of Prostate-Specific Antigen Testing Among Black Individuals

2025 · Jenney R. Lee, Dante’ Morehead, et al. · JAMA Network Open · 3

Mp70-10 Drivers and Barriers to Accessing Prostate Specific Antigen Screening for Early Detection of Prostate Cancer Among Black Men

2024 · Jenney R. Lee, Dante’ Morehead, et al. · The Journal of Urology

Abstract A049: Community partnership to empower Black men to drive research to identify barriers to prostate cancer early detection and equitable care

2023 · Jenney R. Lee, Dante' Morehead, et al. · Cancer Epidemiology Biomarkers & Prevention

Works count: 6

Citation count: 340

H-index: 3

I10-index: 2